The Effect of Non-invasive Brain Stimulation rTMS on Hand Muscles in Chronic Stroke Patients.
Part of paid clinical trials in Durham, North Carolina.
- Sponsor
- Duke University
- Study ID
- NCT06765642
- Status
- Recruiting
Conditions
- Arm Weakness as a Consequence of Stroke
- Brain Stimulation
- Chronic Stroke Patients
- Chronic Stroke Survivors
- Motor Learning
- Stroke
- Stroke Patients
- Transcranial Magnetic Stimulation
- Transcranial Magnetic Stimulation Repetitive
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Transcranial Magnetic Stimulation — DIAGNOSTIC_TESTThe use of this approach aims to potentially maximize motor recovery in chronic stroke by harnessing corticospinal plasticity and modulating motor learning behavior.
Study Details
The study is about using a brain stimulation technique called rTMS (Repetitive Transcranial Magnetic Stimulation) to help improve hand muscles in people who had a stroke. Researchers want to understand how this device can help stroke patients use their hands better.
Key Dates
- Start date
- Jun 9, 2025
- Status verified
- May 2026
- Primary completion
- Apr 13, 2027
- Completion
- Apr 30, 2027
Study Design
- Enrollment
- 26 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Non-invasive Brain Stimulation ModalitiesAll participants will undergo three non-invasive brain stimulation modalities: 1. Focal conventional iTBS over the ipsilesional motor cortex (i.e., a single bout of 600 pulses over a single spot; FiTBS600). 2. Focal high dose iTBS over the ipsilesional motor cortex (i.e. 4 bouts of 600 pulses over a single spot = 2400 pulses; FiTBS2400). 3. Diffuse high dose iTBS over the ipsilesional motor cortex (i.e. 4 bouts of 600 pulses over 4 spots: 600 pulses/spot × 4 spots = 2400 pulses; DiTBS2400)
Primary Outcome Measure
To determine whether there is overall stimulation effect among three stimulation paradigms (FiTBS600; FiTBS2400; DiTBS2400) on the ipsilesional corticospinal excitability of a hand muscle. [ Time Frame: Baseline, prior to and after intervention (Pre0 and Pre1; 45 minutes apart) ]
Central Contacts
- Wuwei Feng, MD919 681 1700
- Megan N Gonzalez, MS9196687597
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Duke University Medical Center | Durham | North Carolina | 27710 |
Find similar trials in Durham, NC
By condition
By specialty
By research site
Related Studies
- Genetic and Environmental Risk Factors for Hemorrhagic StrokeRecruiting · State University of New York at Buffalo · Chicago, Illinois
- GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyRecruiting · W.L.Gore & Associates · Tucson, Arizona
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPHASE3 · Recruiting · Icahn School of Medicine at Mount Sinai · Little Rock, Arkansas
- Xeomin® and Gait Related Mobility After StrokePHASE4 · Recruiting · Wake Forest University Health Sciences · Charlotte, North Carolina